Wysa

Mayden and Wysa collaborate on Mental Health etriage

 

Digital Health Rewired, London, 16th March 2022:  Mayden, the company behind the biggest digital care record system for psychological therapies, has partnered with Wysa, the world’s most advanced conversational AI for mental health, enabling the integration of a new etriage with iaptus, Mayden’s digital care record (DCR) for psychological therapy services. This will create a safe environment for patients, provide faster access and deliver more personalised care.

The new etriage system uses Wysa’s AI chatbot to enable interactive digital self-referral to talking therapy services. It will allow patients to access the care system faster, as well as releasing admin and clinical time, supporting improved access for patients. For the first time in the UK, Wysa will share real time patient data with clinicians during the waiting period, to help identify high risk responses and flag for crisis attention. 

As one of the most downloaded mental health support apps on the planet, Wysa has facilitated over 100 million conversations in 65 countries across the globe and was recently selected for a £1m NIHR/NHS randomised control trial. Wysa has also achieved the highest possible rating on ORCHA, the Organisation for the Review of Care and Health Applications, which independently audits healthcare apps to help NHS providers choose from the 370,000 healthcare apps available. iaptus is the market leading digital care record system supporting over 180 psychological therapy services. iaptus offers tools to improve outcomes for patients, enhance patient engagement and increase service efficiency. The collaboration will support thousands of patients entering IAPT services up and down the country.  

“We cannot solve the UK’s growing mental health crisis without credible real-time data. The integration of Wysa’s innovative digital technology with Mayden’s iaptus records will create a safer environment where clinicians have real-time access to the information they need, where they need it, to effectively treat patients,” said Emma Selby, UK Clinical Lead at Wysa. 

Selby added: “Partnerships like this enable us to take a revolutionary approach that streamlines the system, ensuring that those who need treatment can access the professional support they need, fast. But more importantly, it’s about patient safety. About creating an environment where nothing and no-one slips through the cracks of the system.” 

“We look to work with innovators that are the best in their class to bring to our customers something that will elevate patient services and streamline workflows for clinicians and administrators,” said Fiona Dawson, Director at Mayden. “With so many digital health apps available it’s hard for NHS providers to evaluate which are compliant, safe and effective. Our customers trust us to ensure the most credible digital tools integrate with iaptus. Wysa is an exciting addition, being such a popular mobile download and consistently achieving high user ratings. But more importantly Wysa have worked closely with the NHS and regulatory bodies, giving our customers the confidence to adopt Wysa for talking therapy etriage,”  Dawson concluded. 

Ross O’Brien, MD Wysa UK Ltd,  said: “Wysa’s synergy with Mayden is further evidence of our efforts to set new standards in the use of digital tools in mental health treatment. More NHS talking therapy services use iaptus than any other digital records platform; making it available for millions of people. Additionally, we have achieved exceptional ratings on ORCHA, which means that patients and therapists can be assured that Wysa is safe and effective.” 

O’Brien added: “There is a direct relationship between the length of time a patient waits, and how likely they are to complete their treatment and recover. This project means that when a person reaches out for help, they aren’t left waiting. Instead, they are proactively engaged and that is so important for both patients and services. When they start seeing the therapist, a relationship  will already have been established, so the initial digital experience makes the entry into care much more human.”

 

How it will work

Patients will complete the NHS talking therapy self-referral questions under the interactive guidance of Wysa’s AI chatbot. The referral experience, which can be unpleasant for patients because of the length and intensity of the questionnaires, will be broken up with self-care activities which the companies anticipate will increase completion rates. 

The Wysa platform will track patient symptoms to automatically identify high risk responses which will be flagged for crisis attention. The system will work by securely transmitting patient data from Wysa’s e-triage platform to Mayden’s iaptus digital care record system, ready for transferring to a clinician for assessment. 

The Wysa AI chatbot will then provide interactive, evidence-based CBT self-care modules while the patient is waiting for therapy. By offering immediate support, patients can begin their recovery and avoid further deterioration.

 

Support for the NHS mental health crisis

This partnership is the latest step in Wysa’s efforts to help NHS patients access the support they need as quickly and efficiently as possible. To that end, the world-leading AI-driven support app is already engaged in a £1million Randomised Control Trial (RCT) to further its clinical compatibility with the NHS.

 

About Wysa:

Wysa is a global leader in AI-driven mental health support, available both to individuals and through employer benefits programs. Wysa helps in dealing with stress, depression, and anxiety with the help of an “emotionally intelligent” bot, which uses evidence-based cognitive-behavioral techniques (CBT), meditation, breathing and mindfulness exercises, as well as micro-actions to help users build mental resilience skills. Wysa has facilitated over 100 million conversations in 65 countries across the globe. Wysa works with 20 enterprise partners to support 7 million employees worldwide, with partners that include the Ministry of Health in Singapore, Accenture Global, Aetna International and L’Oreal.

www.wysa.io